Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation.
about
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimenCyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat.Characterization of the gene encoding pinin/DRS/memA and evidence for its potential tumor suppressor functionDirect interaction and cooperative role of tumor suppressor p16 with band 3 (AE1).p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma.Prediction of the axillary lymph node status in mammary cancer on the basis of clinicopathological data and flow cytometry.Expression of cell cycle proteins in male breast carcinoma.Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence.Genetic and environmental melanoma models in fishFosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studiesA distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient.Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma.Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR.Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumorsMelanoma susceptibility and cell cycle genes in Xiphophorus hybrids.The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomasp16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cellsGastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.Nuclear p16INK4a expression predicts enhanced radiation response in head and neck cancers.p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.Gastrin suppresses the interdependent expression of p16 and anion exchanger 1 favoring growth inhibition of gastric cancer cells.Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells.Functional reassessment of P16 variants using a transfection-based assay.Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma.Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma.Novel findings about management of gastric cancer: a summary from 10th IGCC.Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy.Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas.Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.Co-expression of p16 and p53 characterizes aggressive subtypes of ductal intraepithelial neoplasia.
P2860
Q21092375-0F6BF933-DB32-407B-A76F-2DD3A2182098Q24791191-264AAB4F-9C38-4328-AAEC-41AD7DBA7E0EQ28143178-3CFB4C98-1044-42B6-A660-C62A8D78FCA4Q31157467-6A0B8E18-BD5B-4FC8-828A-9067621F0113Q33209538-D32029FC-0F86-4102-8C3C-3512E3D80502Q33209697-1D045326-9648-4E7E-B670-029FB039185BQ33692284-A64449D9-4F4D-4CD7-B6BF-86FB7FA09AF0Q33869183-6A05942B-2A67-4CAA-B656-035524F69161Q33895966-E9E3B364-909F-4E51-8B74-E53067325251Q34179474-813B4210-C5CD-4196-B582-07729EF72857Q34208771-7E0CB4DA-C059-47EE-A1A6-8A6E3E935149Q34248718-ABC9CAC5-67C2-4358-9D3A-93CDF63DFF55Q35355110-19FE3B50-C4B3-4442-9D66-BD3917DDD0F3Q35573116-600FCEDA-5373-4AAA-B957-F37E29532169Q35602168-32248587-7F8A-47FA-A576-FFDBCEB51456Q35619493-C5FF9A51-CD9F-4678-AED3-B1F8E1C42A15Q36088632-2C694B86-5DF1-4AA0-B76D-A0BE951CC0E1Q36117164-88EB8D3C-27D9-4FA2-A073-666415FCBFBBQ36407378-DB1D61E1-B3CD-409A-A3A2-D89F79D2BDA9Q36518767-74B34A46-A18A-4F7D-BD78-F078AFE0924AQ36622669-D7178BB9-E5B0-4752-9F8C-1218152AA395Q36646282-B95FC11B-5618-4B5A-B0C7-E93CF81B9A12Q36707456-5420CCBD-DB47-4DAF-A183-4F91C6E6017BQ36810122-3BB09450-29FB-4344-9622-2398DC7E3243Q37038629-6A27A4B8-9293-468A-BB03-CD494FDB35F9Q37042920-464F5544-0B30-43E6-93F3-1368BEA5523DQ37179471-84E70645-087F-45AB-969A-8EAAFF4912A0Q37437660-44CF22C2-9952-455C-8F4F-B7144DA728BBQ37836381-4D2ABF7E-80BB-4A5D-916C-7E229428E958Q39761610-28786439-647B-402F-8B63-49F88607E017Q40373769-CF2D3948-FCFE-4B2D-B79B-DA26E1637D13Q40944770-5406D8B6-C5F8-4AA4-AB1B-B5A9588A9EE5Q41593112-E51BFF8D-801B-4FAF-908F-B92DA438FFF0Q41909099-F6E1039A-65E6-4E8F-8F0A-BB37B213B7E7Q42751821-D76BC5DF-1EE5-48BD-AF02-0397311CE35DQ43716774-6B30FE2F-05B6-4E81-8A09-3BB53D766292Q43862141-F8A201BD-A91B-4A41-A1F5-82F98F3A0C7CQ47273051-B36935F4-C05E-4A1E-A92A-29674F93C004Q48584099-F6F20FFE-9662-42E5-93FA-8AA718EB3164Q51467842-EC986AB6-38CD-4CAF-B75B-6C445F9EE87C
P2860
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@ast
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@en
type
label
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@ast
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@en
prefLabel
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@ast
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@en
P2093
P2860
P356
P1476
Aberrant cytoplasmic expressio ...... elerated tumour proliferation.
@en
P2093
Stilgenbauer F
Volkmann M
Wallwiener D
P2860
P2888
P304
P356
10.1038/BJC.1998.739
P407
P577
1998-12-01T00:00:00Z